1. Home
  2. PTCT vs GBCI Comparison

PTCT vs GBCI Comparison

Compare PTCT & GBCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$62.76

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Logo Glacier Bancorp Inc.

GBCI

Glacier Bancorp Inc.

HOLD

Current Price

$43.66

Market Cap

6.3B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTCT
GBCI
Founded
1998
1955
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
6.3B
IPO Year
2006
1996

Fundamental Metrics

Financial Performance
Metric
PTCT
GBCI
Price
$62.76
$43.66
Analyst Decision
Buy
Strong Buy
Analyst Count
17
5
Target Price
$79.41
$53.60
AVG Volume (30 Days)
1.0M
966.7K
Earning Date
05-12-2026
01-01-0001
Dividend Yield
N/A
2.98%
EPS Growth
264.48
18.45
EPS
7.78
1.99
Revenue
$264,734,000.00
N/A
Revenue This Year
N/A
$30.38
Revenue Next Year
$21.65
$8.37
P/E Ratio
$8.14
$22.36
Revenue Growth
36.19
N/A
52 Week Low
$35.95
$36.76
52 Week High
$87.50
$53.99

Technical Indicators

Market Signals
Indicator
PTCT
GBCI
Relative Strength Index (RSI) 21.26 30.64
Support Level $57.74 $43.01
Resistance Level $63.19 $43.90
Average True Range (ATR) 2.77 1.59
MACD -0.57 -0.77
Stochastic Oscillator 8.82 14.98

Price Performance

Historical Comparison
PTCT
GBCI

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

About GBCI Glacier Bancorp Inc.

Glacier Bancorp Inc is a regional bank holding company providing commercial banking services to scores of communities through its wholly-owned bank subsidiary, Glacier Bank. The bank operates a multitude of banking offices in Montana, Idaho, Colorado, Utah, Washington, and Wyoming. The bank's various products and services include deposit, loans, and mortgage origination services, among others. The bank predominantly serves individuals, small- to medium-sized businesses, community organizations, and public entities. Glacier emphasizes both internal growth and growth through selective acquisitions. A majority of the bank's loan portfolio is in commercial real estate, while a majority of its net revenue is net interest income.

Share on Social Networks: